
    
      This is a randomized, 3-arm, parallel group, double blind study to evaluate the efficacy and
      safety of TA-7284 in Japanese patients with Type 2 diabetes mellitus, who are not optimally
      controlled on diet and exercise. The patients will receive either TA-7284-Low, TA-7284-High
      or Placebo orally alone for 24 weeks.
    
  